Patents by Inventor Ralf AMANN

Ralf AMANN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY
    Publication number: 20240043870
    Abstract: The present invention relates to a modified Parapoxvirus, preferably a Parapoxvirus vector, having an increased munogenicity, a biological cell containing said modified Parapoxvirus, a pharmaceutical composition, preferably a vaccine, containing said modified Parapoxvirus vector and/or said cell, and a new use of said modified Parapoxvirus.
    Type: Application
    Filed: December 14, 2021
    Publication date: February 8, 2024
    Inventors: Ralf AMANN, Ferdinand SALOMON
  • MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY
    Publication number: 20240024464
    Abstract: The present invention relates to a modified Parapoxvirus, preferably a Parapoxvirus vector, having an increased immunogenicity, a biological cell containing said modified Parapoxvirus, a pharmaceutical composition, preferably a vaccine, containing said modified Parapoxvirus and/or said cell, and a new use of said modified Parapoxvirus.
    Type: Application
    Filed: December 14, 2021
    Publication date: January 25, 2024
    Inventors: Ralf AMANN, Ferdinand SALOMON
  • RECOMBINANT POXVIRIDAE VECTOR EXPRESSING CO-STIMULATORY MOLECULES
    Publication number: 20230338516
    Abstract: The present invention relates to a recombinant Poxviridae vector expressing a co-stimulatory molecule, a cell containing the recombinant Poxviridae vector, a pharmaceutical composition containing the recombinant Poxviridae vector according to the invention and/or the cell according to the invention, and a method for the treatment of a living being in need of a vaccination with an antigen.
    Type: Application
    Filed: August 16, 2021
    Publication date: October 26, 2023
    Inventors: Melanie MUELLER, Ralf AMANN
  • RECOMBINANT ORF VIRUS VECTOR
    Publication number: 20220204992
    Abstract: A nucleic acid molecule can code for an Orf virus vector promoter. A recombinant Orf virus vector can be included in a cell. The nucleic acid molecule, the vector and/or the cell can be included in a composition. The recombinant Orf virus vector can be used for the production of a foreign gene.
    Type: Application
    Filed: March 17, 2022
    Publication date: June 30, 2022
    Inventors: Hanns-Joachim Rziha, Ralf Amann
  • Recombinant Orf virus vector
    Patent number: 11286500
    Abstract: A nucleic acid molecule can code for an Orf virus vector promoter. A recombinant Orf virus vector can be included in a cell. The nucleic acid molecule, the vector and/or the cell can be included in a composition. The recombinant Orf virus vector can be used for the production of a foreign gene.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: March 29, 2022
    Assignee: EBERHARD KARLS UNIVERSITÄT TÜBINGEN MEDIZINISCHE FAKULTÄT
    Inventors: Hanns-Joachim Rziha, Ralf Amann
  • Production of recombinant expression vectors
    Patent number: 10655134
    Abstract: The present invention relates to a method for the production of recombinant expression vectors, a kit adapted to carrying out the method, a vector used in the context of the method, a cell containing such vector and the use of the vector.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: May 19, 2020
    Assignee: EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAETGESCHWISTER-SCHOLL-PLATZ
    Inventors: Ralf Amann, Hans-Joachim Rziha
  • RECOMBINANT ORF VIRUS VECTOR
    Publication number: 20180148739
    Abstract: A nucleic acid molecule can code for an Orf virus vector promoter. A recombinant Orf virus vector can be included in a cell. The nucleic acid molecule, the vector and/or the cell can be included in a composition. The recombinant Orf virus vector can be used for the production of a foreign gene.
    Type: Application
    Filed: January 19, 2018
    Publication date: May 31, 2018
    Inventors: Hans-Joachim Rziha, Ralf Amann
  • PRODUCTION OF RECOMBINANT EXPRESSION VECTORS
    Publication number: 20170240907
    Abstract: The present invention relates to a method for the production of recombinant expression vectors, a kit adapted to carrying out the method, a vector used in the context of the method, a cell containing such vector and the use of the vector.
    Type: Application
    Filed: May 9, 2017
    Publication date: August 24, 2017
    Applicant: Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet
    Inventors: Ralf AMANN, Hans-Joachim RZIHA